Anti-SC6A3/ DAT/ SLC6A3 monoclonal antibody

Anti-SC6A3/ DAT/ SLC6A3 antibody for FACS & in-vivo assay

Target products collectionGo to DAT/SLC6A3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T55959-Ab-1/ GM-Tg-hg-T55959-Ab-2Anti-Human DAT/SLC6A3 monoclonal antibodyHuman
GM-Tg-rg-T55959-Ab-1/ GM-Tg-rg-T55959-Ab-2Anti-Rat DAT/SLC6A3 monoclonal antibodyRat
GM-Tg-mg-T55959-Ab-1/ GM-Tg-mg-T55959-Ab-2Anti-Mouse DAT/SLC6A3 monoclonal antibodyMouse
GM-Tg-cynog-T55959-Ab-1/ GM-Tg-cynog-T55959-Ab-2Anti-Cynomolgus/ Rhesus macaque DAT/SLC6A3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T55959-Ab-1/ GM-Tg-felg-T55959-Ab-2Anti-Feline DAT/SLC6A3 monoclonal antibodyFeline
GM-Tg-cang-T55959-Ab-1/ GM-Tg-cang-T55959-Ab-2Anti-Canine DAT/SLC6A3 monoclonal antibodyCanine
GM-Tg-bovg-T55959-Ab-1/ GM-Tg-bovg-T55959-Ab-2Anti-Bovine DAT/SLC6A3 monoclonal antibodyBovine
GM-Tg-equg-T55959-Ab-1/ GM-Tg-equg-T55959-Ab-2Anti-Equine DAT/SLC6A3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T55959-Ab-1/ GM-Tg-hg-T55959-Ab-2; GM-Tg-rg-T55959-Ab-1/ GM-Tg-rg-T55959-Ab-2;
GM-Tg-mg-T55959-Ab-1/ GM-Tg-mg-T55959-Ab-2; GM-Tg-cynog-T55959-Ab-1/ GM-Tg-cynog-T55959-Ab-2;
GM-Tg-felg-T55959-Ab-1/ GM-Tg-felg-T55959-Ab-2; GM-Tg-cang-T55959-Ab-1/ GM-Tg-cang-T55959-Ab-2;
GM-Tg-bovg-T55959-Ab-1/ GM-Tg-bovg-T55959-Ab-2; GM-Tg-equg-T55959-Ab-1/ GM-Tg-equg-T55959-Ab-2
Products NameAnti-DAT/SLC6A3 monoclonal antibody
Formatmab
Target NameDAT
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-DAT benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SC6A3/ DAT/ SLC6A3 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm003098mouse Slc6a3 Lentivirus plasmid
    ORF Viral VectorvGMLPm003098mouse Slc6a3 Lentivirus particle


    Target information

    Target IDGM-T55959
    Target NameDAT
    Gene ID6531,13162,24898,574143,609304,101101618,788410,100054747
    Gene Symbol and SynonymsDAT,DAT1,PKDYS,PKDYS1,SLC6A3
    Uniprot AccessionQ01959,P23977,P27922
    Uniprot Entry NameSC6A3_HUMAN,SC6A3_RAT,SC6A3_BOVIN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000142319
    Target ClassificationN/A

    The target: DAT, gene name: SLC6A3, also named as DAT, DAT1, PKDYS, PKDYS1. This gene encodes a dopamine transporter which is a member of the sodium- and chloride-dependent neurotransmitter transporter family. The 3' UTR of this gene contains a 40 bp tandem repeat, referred to as a variable number tandem repeat or VNTR, which can be present in 3 to 11 copies. Variation in the number of repeats is associated with idiopathic epilepsy, attention-deficit hyperactivity disorder, dependence on alcohol and cocaine, susceptibility to Parkinson disease and protection against nicotine dependence.[provided by RefSeq, Nov 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.